Loading...
OTCM
ULGX
Market cap0kUSD
Mar 12, Last price  
0.00USD
1Q
-99.00%
Jan 2017
-99.91%
Name

21st North Inc

Chart & Performance

D1W1MN
OTCM:ULGX chart
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
3.15%
Revenues
Net income
CFO

Profile

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
IPO date
May 30, 1996
Employees
61
Domiciled in
US
Incorporated in
US

Valuation

No data to show